The GLOW blend is a three-peptide research formulation combining BPC-157, TB-500, and GHK-Cu in a single lyophilized vial. It is designed for research protocols studying coordinated cellular repair, angiogenesis, extracellular matrix regulation, and collagen-associated signaling in a single administration. Typically supplied as a 60mg combined vial.
Why researchers use the blend
Using a pre-formulated blend eliminates the need to source, reconstitute, and administer three separate compounds. Each peptide in the GLOW blend targets a distinct research pathway: BPC-157 focuses on angiogenic and fibroblast signaling, TB-500 on actin regulation and cell migration, and GHK-Cu on extracellular matrix remodeling and copper-dependent redox signaling. Together they allow researchers to study multi-pathway coordination in a single experimental condition.
GLOW vs KLOW
GLOW contains three peptides: BPC-157, TB-500, and GHK-Cu. KLOW extends this by adding KPV — a tripeptide derived from alpha-MSH studied for anti-inflammatory and epithelial integrity signaling. If your research protocol specifically involves inflammation modulation as a primary variable, KLOW provides the additional KPV dimension. GLOW is the starting point for most regenerative and skin biology research models.
COA requirements for blends
Multi-peptide blends require more rigorous COA documentation than single compounds. A legitimate blend COA should include HPLC and mass spec verification for each individual component, not just a composite purity figure. Paramount Peptides and Ascension Peptides both provide component-level verification for their blend products.
See all GLOW Blend vendors ranked
PeptideComparison independently scores every vendor on COA quality (weighted 2×), price, reviews, shipping, and availability. Click below to see the full ranked list filtered to GLOW Blend vendors.
View GLOW Blend vendor rankings →